A phase Ib trial of neoadjuvant oncolytic virus OrienX010 (ori) and anti-PD-1 toripalimab (tori) combo in patients (pts) with resectable stage IIIb-IV (M1a) acral melanoma-MedSci.cn

A phase Ib trial of neoadjuvant oncolytic virus OrienX010 (ori) and anti-PD-1 toripalimab (tori) combo in patients (pts) with resectable stage IIIb-IV (M1a) acral melanoma

Wei, X; Wang, X; Bai, X; Li, C; Mao, L; Chi, Z; Lian, B; Bixia, T; Kong, Y; Dai, J; Andtbacka, RHI; Guo, J; Cui, CL; Si, L

ANNALS OF ONCOLOGY, 2022; 33 (7): S907